Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Ajanta Pharma Business Update

Ajanta Pharma disclosed that the US FDA inspection of its Paithan facility resulted in a Voluntary Action Indicated classification. The filing is for regulatory update only.

Source

BSE filing, NSE: AJANTPHARM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ajanta Pharma Ltd: key numbers

Share price
₹3,508.80
Market cap
₹43,846 Cr
Revenue (annual)
₹5,453 Cr
Net profit (annual)
₹1,056 Cr
P/E (TTM)
34.7×Sector 45.9×
Promoter holding
63.47%-0.01% QoQ
FII holding
7.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ajanta Pharma Ltd

All →
12:55 IST BSE
Financial Results

Ajanta Pharma Q2 FY27 Results: Net Profit ₹388.1 Cr, Up 49.2% YoY

Ajanta Pharma Ltd reported revenue from operations of ₹1,794 Cr (+32.5% YoY) and net profit of ₹388.1 Cr (+49.2% YoY) for Q2 FY27.

Key figure
Net profit ₹388.1 Cr · +49.2% YoY

Other business update announcements

All →